- Lupin reported a 16.1% YoY increase in net profit to ₹1,415 crore and a 33.3% YoY surge in revenue to ₹8,217 crore.
- The US business remained the largest contributor, with revenue rising to $366 million from $282 million a year ago.
- Managing Director Nilesh Gupta stated that the company began FY27 on a strong note, with robust growth across key markets and improved profitability.
- Brokerage Macquarie has an 'Outperform' rating with a price target of ₹2,750, noting revenue, EBITDA, and PAT exceeded estimates by 7%, 23%, and 17%, respectively.
- EBITDA rose 47.3% to ₹2,390 crore, and EBITDA margin expanded by 280 basis points to 29.1%.
- Domestic sales in India increased 14% to ₹2,379.6 crore, other developed markets grew 48.3% to ₹1,149.4 crore, and emerging markets revenue climbed 51.7% to ₹989.7 crore.
- Lupin invested ₹607.7 crore (or 7.4% of sales) in R&D and ₹278.6 crore in capital expenditure during the quarter.
Lupin's Q1 results reflect a robust performance, with net profit increasing by 16.1% to ₹1,415 crore, up from ₹1,219 crore a year earlier.12
Revenue surged 33.3% to ₹8,217 crore, driven by strong sales in the US, which contributed $366 million, up from $282 million.3
Operating performance was impressive, with EBITDA rising 47.3% to ₹2,390 crore, leading to an EBITDA margin expansion of 280 basis points to 29.1%.78
Domestic sales in India increased by 14% to ₹2,379.6 crore, while other developed markets saw a 48.3% growth to ₹1,149.4 crore.910
Emerging markets also showed strong momentum, with revenue climbing 51.7% to ₹989.7 crore.
Lupin invested ₹607.7 crore, or 7.4% of sales, in research and development during the quarter, with capital expenditure at ₹278.6 crore.11
Managing Director Nilesh Gupta commented on the results, stating that the company began FY27 on a strong note, supported by robust growth across key markets and improved profitability.4
He emphasized that Lupin's focus on execution, operational excellence, technology, and innovation would drive sustainable long-term growth.
Brokerage firm Macquarie has an 'Outperform' rating on Lupin with a price target of ₹2,750.56
The brokerage noted that the company exceeded estimates for revenue, EBITDA, and profit after tax by 7%, 23%, and 17%, respectively.
Lupin shares ended Thursday's session at ₹2,388.30, gaining around 14% in 2026 and about 10% over the past six months.
“EBITDA jumped 47.3% to ₹2,390 crore with margin expanding 280 basis points to 29.1%, while US revenue climbed to $366 million from $282 million. Macquarie maintained an 'Outperform' rating with a ₹2,750 price target, noting revenue, EBITDA, and PAT beat estimates by 7%, 23%, and 17% respectively.”
CNBC TV18
